This article considers the challenges and potential benefits of combining the two. The nasal delivery of biologics offers considerable potential for both local and systemic action and for direct access to the brain and CNS to address currently unmet therapeutic need. The unique features of biologics are discussed with reference to the associated difficulties of nasal delivery and the benefits of partnership with experts such as Aptar Pharma is highlighted. Work on the development of vaccines and prophylactics for COVID-19 illustrates what is achievable.
Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery
This Might Also Be of Interest
Using Raman for the characterization of nasal drug suspension products
Publications, Pharmaceutical, Product Solutions, Innovation & Insights, Device Innovations
The New Imperative
Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Market Insights, Product Solutions
Case Study – Pre-Clinical Respiratory Research with PADA
Case Studies, Pharmaceutical, Innovation & Insights, Device Innovations, Product Solutions
Intranasal Immunization: Promises and Challenges
Webinars, Pharmaceutical, Product Solutions, Sustainability, Innovation & Insights, Device Innovations, Market Insights
